Purchase Order 75N93023P01078
Award Date 8/21/23
Potential Completion Date 1/31/24
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The University of North Carolina at Chapel Hill, operating through its Office of Sponsored Research, has been awarded a $10,550 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, UNC will provide Collaborative Cross mice for tick-borne disease studies to the NIH's Rocky Mountain Laboratories, delivering the mice over a one year period of performance from October 2023 through October 2024. The...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $22,160.00 firm fixed-price purchase order to the University of North Carolina at Chapel Hill (UNC-CH) to provide Collaborative Cross (CC) mice for tick-borne disease studies being conducted at Rocky Mountain Laboratories (RML). The award has an ultimate completion date of October 15, 2024 and does not utilize a set-aside designation. This...
- The University of North Carolina at Chapel Hill received a delivery order valued at $563,541 under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract. The award, issued on May 23, 2022, with an ultimate completion date of October 1, 2026, supports Task A68: Screening Vaccine (and Other Biologics) Platform Technologies Using Coronavirus Mouse Immunogenicity as a Model System. This cost-plus-no-fee delivery order,...
- This federal contract award, valued at $3,242,849.07, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH). The contract is a delivery order under the larger NIAID Preclinical Models of Infectious Diseases 2017-2024 contract vehicle. The contract does not have a set-aside designation. Under this award, UNC-CH will provide pre-clinical models...
- This is a $149,883 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC) for the "Southern Tick-Associated Rash Illness" requirement. The contract does not have a set-aside designation. UNC, operating through its Office of Sponsored Research, is a public research university that has extensive experience providing scientific...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) to provide pre-clinical research services for infectious disease studies. The $2,221,849 contract is a Delivery Order under a larger $146.3 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract with UNC-CH that runs through July 2031. The IDIQ supports...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $146,246 firm fixed price purchase order to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) to provide immunological data on 9 vaccines. The award does not have a set-aside designation. UNC-Chapel Hill, through its Kenan Flagler Business School, has provided various training and research services to federal agencies, including the Centers for...
- This is a $9,122.52 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) on August 12, 2015. The contract has an ultimate completion date of August 31, 2015 and was not set aside for any specific business category. UNC-Chapel Hill is a U.S. state government entity and institution of higher learning that...
- This is a $2,837,144.17 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of North Carolina at Chapel Hill (UNC-CH) on September 30, 2020. The contract is for characterizing and improving humanized immune system mouse models (IMM-HIS) and has a performance period through March 31, 2025. The contract was not set aside for any specific business type. The original solicitation was a Broad Agency Announcement from...
- The federal contract award, valued at $565,343.09, was issued by the National Institute of Environmental Health Sciences (NIEHS) to the University of North Carolina at Chapel Hill (UNC-Chapel Hill) to provide gnotobiotic rodent services. This is a firm-fixed-price purchase order contract with a period of performance through September 15, 2023. UNC-Chapel Hill, through its Kenan Flagler Business School, has a history of providing educational services, training programs, and consulting to...
The University of North Carolina at Chapel Hill, operating through its Office of Sponsored Research, has been awarded a $23,765 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, UNC will provide two batches of Collaborative Cross mice for tick-borne disease studies being conducted at the Rocky Mountain Laboratories in Hamilton, Montana. No subcontractors or set aside designations were specified. This award is likely in support of NIAID's broader infectious disease research efforts focused on understanding and combating illnesses transmitted by ticks such as Lyme disease, anaplasmosis, and Rocky Mountain spotted fever.
Generated 12/14/23, 4:50 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 8/14/23 |